Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Fahad Waqar

Interventional Cardiology Cincinnati, OH Medical Doctor

NPI 1801022264 CMS profile 728145

234 Goodman St, Cincinnati, OH 45219

Open in the dashboard

General payments

$4,170

80 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Fahad Waqar of Cincinnati, OH is reported in the CMS Open Payments database as having received $4,170 across 80 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 34th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $549 12
2024 General $373 13
2023 General $400 14
2022 General $124 4
2021 General $48 3
2020 General $25 2
2019 General $2,651 32

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Fahad Waqar
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Fahad Waqar were reported at $549. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Fahad Waqar Interventional Cardiology median Middle half National median
2019 $2,651 $1,097 $329–$3,048 $163
2020 $25 $473 $161–$1,480 $114
2021 $48 $677 $233–$1,827 $132
2022 $124 $978 $333–$2,724 $149
2023 $400 $1,136 $382–$2,986 $160
2024 $373 $1,181 $395–$3,326 $164
2025 $549 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Edwards Lifesciences Corporation $1,508 12 payments
  2. Boston Scientific Corporation $1,151 18 payments
  3. Inari Medical, Inc. $320 4 payments
  4. Novartis Pharmaceuticals Corporation $263 17 payments
  5. Philips Electronics North America Corporation $179 2 payments
  6. Abbott Laboratories $171 3 payments
  7. Imperative Care, INc $139 4 payments
  8. Stryker Corporation $106 2 payments
  9. Reflow Medical Inc $95 2 payments
  10. Cardiva Medical, Inc. $87 4 payments
  11. Other $151 12 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,262 70 payments
  2. Travel and Lodging $1,840 9 payments
  3. Education $68 1 payment
Products named General payments · program years 2019–2025
  1. ANGIOJET $850 5 payments
  2. FLOWTRIEVER CATHETER, S $320 4 payments
  3. CT THROMBECTOMY SYSTEM KIT $320 4 payments
  4. LEQVIO $213 13 payments
  5. ENTRESTO $211 14 payments
  6. SAPIEN 3 Ultra RESILIA $199 1 payment
  7. SYMPHONY CATHETER $139 4 payments
  8. OPTIS $136 1 payment
  9. Lasers $111 1 payment
  10. FLOWTRIEVER $106 2 payments
  11. Other $679 36 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 26 drugs

Part D claims

1,474

Median for Internal Medicine: 777

Drug cost

$206,529

Median for Internal Medicine: $73,373

Branded share of claims

29.4%

Median for Internal Medicine: 19.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 98 $110,708
Entresto Sacubitril/Valsartan Brand 43 $39,176
Repatha Sureclick Evolocumab Brand 28 $22,970
Brilinta Ticagrelor Brand 28 $20,842
Atorvastatin Calcium Generic 252 $2,236
Metoprolol Succinate Generic 168 $1,602
Prasugrel Hcl Generic 25 $1,330
Clopidogrel Clopidogrel Bisulfate Brand 123 $966
Ranolazine Er Ranolazine Brand 15 $912
Carvedilol Generic 109 $810

The 10 drugs with the highest cost, of 26 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 104,182 Part D prescribers listed as Internal Medicine; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 51 billing codes

Paid by Medicare

$81,529

Medicare's payments for the services billed

Medicare patients

599

Average age 75

Services billed

1,398

292 women, 307 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 69%
Arthritis 56%
Heart failure 48%
Atrial fibrillation 42%
Diabetes 37%
Chronic kidney disease 36%
Depression 32%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
LEQVIO
  • Novartis Pharmaceuticals Corporation $26
$26 — —
ENTRESTO
  • Novartis Pharmaceuticals Corporation $26
$26 43 —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

80 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record